Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Biochemical Engineering >  Biochemical Reagents >  Agonist Inhibitors >  AC710

AC710

Basic information Safety Supplier Related

AC710 Basic information

Product Name:
AC710
Synonyms:
  • AC710
  • N-[4-[[[[5-(1,1-Dimethylethyl)-3-isoxazolyl]amino]carbonyl]amino]phenyl]-5-[(1-ethyl-2,2,6,6-tetramethyl-4-piperidinyl)oxy]-2-pyridinecarboxamide
  • 5-[(1-Ethyl-2,2,6,6-tetramethyl-4-piperidinyl)oxy]-N-[4-({[5-(2-methyl-2-propanyl)-1,2-oxazol-3-yl]carbamoyl}amino)phenyl]-2-pyridinecarboxamide
  • N-(4-(3-(5-tert-butylisoxazol-3-yl)ureido)phenyl)-5-(1-ethyl-2,2,6,6-tetramethylpiperidin-4-yloxy)picolinamide
  • CS-2269
  • AC710; AC 710; AC-710
  • N-[4-[[[[5-(1,1-Dimethethylethyl)-3-isoxazolyl]amino]carbonyl]amino]phenyl]-5-[(1-ethyl-2,2,6,6-tetramethyl-4-piperidinyl)oxy]-2-pyridinecarboxamide
  • AC 710; AC-710
CAS:
1351522-04-7
MF:
C31H42N6O4
MW:
562.7
Mol File:
1351522-04-7.mol
More
Less

AC710 Chemical Properties

Boiling point:
580.4±50.0 °C(Predicted)
Density 
1.180±0.06 g/cm3(Predicted)
storage temp. 
Store at -20°C
solubility 
DMSO:13.0(Max Conc. mg/mL);23.1(Max Conc. mM)
form 
A crystalline solid
pka
10.91±0.70(Predicted)
color 
White to off-white
More
Less

AC710 Usage And Synthesis

Uses

AC 710 is a globally selective inhibitor of platelet-derived growth factor receptor-family kinases and has been shown to have potential anti-arthritic theapeutic use.

in vivo

At 0.3 mg/kg of AC710, tumor growth is temporally inhibited, and growth resumes quickly thereafter. At 3 and 30 mg/kg of AC710, tumors regress completely, and the tumor volume stays suppressed for an extended period after dosing is halted. No body weight loss is observed in animals treated with AC710 at all doses, indicating that it is well tolerated in mice at efficacious doses. AC710 exhibits a significant impact on disease in a dose-dependent fashion in a mouse collagen-induced arthritis (CIA) model, at a dose as low as 3 mg/ kg for 15 days (day 0-14). At 10 and 30 mg/kg, AC710 demonstrates equivalent or slightly better efficacy in reducing the joint swelling and inflammation than dexomethasone administered at a safe dose. AC710 is well tolerated at the tested doses[1].

IC 50

PDGFRα: 1.3 nM (Kd); PDGFRβ: 1 nM (Kd); c-Kit: 1 nM (Kd); FLT3: 0.6 nM (Kd); CSF1R: 1.57 nM (Kd)

storage

Store at +4°C

AC710Supplier

Shanghai Boyle Chemical Co., Ltd.
Tel
Email
sales@boylechem.com
BOC Sciences
Tel
1-631-485-4226; 16314854226
Email
info@bocsci.com
Haoyuan Chemexpress Co., Ltd.
Tel
021-58950125
Email
info@chemexpress.com
MedChemexpress LLC
Tel
021-58955995
Email
sales@medchemexpress.cn
LETOPHARM LIMITED
Tel
+86-21-5821 5861
Email
sales@letopharm.com
More
Less

AC710(1351522-04-7)Related Product Information